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ABSTRACT
Objective: Glucosamine hydrochloride (HCl) and chondroitin sulfate are glycosaminoglycan compounds and major structural components of bones 
in the form of proteoglycans. These compounds maintain bone structure by stimulating the synthesis of synovial fluid and inhibiting the degradation 
of joint cartilage, and they can be used for the treatment of osteoarthritis. The aim of this study was to identify a selective analytical method for 
determining glucosamine HCl and chondroitin sulfate levels in tablet and cream forms.
Methods: After derivatization using ortho-phthalaldehyde and 2-mercaptoethanol, the samples were analyzed using high-performance liquid 
chromatography (HPLC) with a fluorescence detector at an excitation wavelength of 335 nm and an emission wavelength of 445 nm. Deacetylation 
using sodium hydroxide was required to break the acetyl group bond. The mobile phase used tetrahydrofuran 0.25% in water-acetonitrile (87:13) 
with a flow rate of 1.5 ml/minute.
Results: The average levels of glucosamine HCl and chondroitin sulfate were 92.76% and 96.11% in tablets and 101.15% and 100.33% in creams, 
which fulfilled the acceptance criteria.
Conclusions: Our validation method for glucosamine HCl and chondroitin sulfate met the acceptance criteria of accuracy, precision, selectivity, and 
linearity.
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INTRODUCTION
Glucosamine (2-amino-2-deoxy-D-glucose) is an amino monosaccharide, 
a component of glycoproteins in connective tissues and mucous 
membranes, involved in the formation of glycosaminoglycans. For two 
decades, the salt forms of glucosamine (hydrochloride [HCl] and sulfate) 
have been used independently or together with other active ingredients 
such as chondroitin sulfate in capsules, tablets, and solutions for oral 
administration. At present, topical forms of glucosamine, such as 
creams, gels, and patches, are being developed by the pharmaceutical 
industry [1]. Glucosamine HCl and chondroitin sulfate are used to 
treat osteoarthritis (OA). Glucosamine HCl stimulates improved joint 
function, and various studies have shown that it reduces the pain of OA, 
rehabilitates cartilage, improves synovial fluid formation, and improves 
joint damage caused by OA. Chondroitin sulfate supports cartilage 
health by absorbing liquids (especially water) into the connective 
tissue, and it can reduce the pain of OA and act as an anti-inflammatory 
medication [2].
The prevalence of OA in Indonesians older than 65 years is 60.5% 
in men and 70.5% in women, with approximately 2 million people 
suffering from a disability due to OA [3]. The increased prevalence of OA 
has led to a growing need for pharmaceuticals containing glucosamine 
and chondroitin. Therefore, a selective analysis method is required to 
ensure the quality of different pharmaceutical delivery forms [4].
Based on a search of literature, analysis of glucosamine HCl can 
be performed using high-performance liquid chromatography 
(HPLC) with a fluorescence detector. Glucosamine HCl does not have 
chromophore groups in the ultraviolet/visible (UV/Vis) spectra, but 
it can form fluorescence compounds after being derivatized with 
a fluorogenic reagent. Commonly used reagents for analyzing the 
derivatization of glucosamine HCl include ortho-phthalaldehyde (OPA), 
phenylisothiocyanate, and 9-fluorenylmethoxycarbonyl chloride [4]. 
Several methods are used to analyze chondroitin sulfate, such as 
titration with cetylpyridinium chloride, which enables the analysis of 
compounds with large molecules such as proteins but not specifically 
chondroitin sulfate [5]. Another technique for analyzing chondroitin 
sulfate is ion exchange chromatography with a fluorescence detector, 
commonly involving enzymatic digestion [6].
Several studies have analyzed mixtures of glucosamine HCl and 
chondroitin sulfate, including isotachophoresis and ionic analyte 
separation techniques using electrophoresis with UV detection at 
254 nm [7]. Ion exchange chromatography is performed using a 
CarboPac PA20 column with potassium hydroxide as the eluent, with 
a flow rate of 0.5 ml/minute at 30°C [8]. Previous studies have also 
used reverse-phase HPLC with a fluorescence detector to analyze a 
mixture of glucosamine HCl and chondroitin sulfate in the Laboratory 
Quality Testing Center of Drugs, Food and Cosmetics Faculty of 
Pharmacy, Universitas Indonesia. The present study aimed to conduct 
further research on the optimization, validation, and determination 
of glucosamine HCl and chondroitin sulfate levels in tablet and cream 
forms using HPLC with a fluorescence detector. The expected advantage 




Standard glucosamine HCl (Sigma-Aldrich, US), standard chondroitin 
sulfate (PT. Dua Lima Farma, Indonesia), Aqua Bidest (PT. Ikapharmindo 
PUTRAMAS, Indonesia), Acetonitrile Pro HPLC (Merck, US/Canada), 
tetrahydrofuran (THF, Mallinckrodt chromAR® HPLC, US), OPA (Bio 
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Basic Inc., Canada), 2-mercaptoethanol (Merck, US/Canada), boric 
acid (Merck, US Canada), and NaOH (Merck, US Canada); Methanol Pro 
HPLC (Merck, US Canada), hydrochloric acid (Merck, US Canada), and 
dichloromethane (Merck, US/Canada).
Samples
Caplet Viostin DS® (Pharos, Indonesia) and Flexamine Cream® (Novell 
Pharmaceutical, Indonesia) were used.
Instruments
LC-20AT (Shimadzu, Japan) equipped with a pump, YMC-Triart® C18 
column (250 × 4.6 mm, 5μm), 20A RF fluorescence detector (Shimadzu, 
Japan), manual injector, data processor, HPLC syringes (SGE, Australia), 
centrifuge (Kubota, Japan), vortex (Thermo Scientific, US), micropipettes 
(Eppendorf, Germany), 0.45 μm filter membranes, analytical balance, 
ultrasonic cleaner (Elma Elmasonic S40H, Germany), and glass tools.
Chromatography system
This study implemented HPLC equipped with a pump, a C18 column, 
and a fluorescence detector at λex=335 nm and λem=445 nm. Mobile 
phase THF in water-acetonitrile (87:13) was used at a flow rate of 
1.5 ml/minute.
Preparation of standard solutions
Standard solution of glucosamine HCl
Standard glucosamine HCl was weighed at 50 mg, then diluted with 
10 ml of methanol:water (2:1), and Aqua Bidest was added up to 50 ml. 
This was diluted to obtain a concentration of 10 μg/ml.
Standard solution of chondroitin sulfate
The chondroitin sulfate standard was weighed at 50 mg, then 10 ml 
of NaOH 6N was added to a 100 ml glass beaker. This was heated at 
60°C for 30 minutes with stirring until homogenized, cooled, and 
then neutralized to pH 7 with HCl 2N. It was then diluted with 10 mL 
of methanol:water (2:1), Aqua Bidest was added up to 50 mL, and the 
mixture was diluted to obtain a concentration of 100 μg/ml.
Preparation of tablet sample solution
Ten tablets were obtained and weighed to calculate the average mass; 
then the tablets were crushed into a homogeneous powder. The tablets 
were equivalent to ±100 mg.
Sample preparation of glucosamine HCl
Tablet samples were weighed to ±216 mg and diluted with 10 ml of 
methanol:water (2:1). The solution was centrifuged at 3500 rpm for 
10 minutes, 5 ml of dichloromethane was added, and the solution was 
shaken for 5 minutes, then allowed to separate. The water layer was 
filtered with 0.45 μm filter membranes. Aqua Bidest was added and 
diluted to a certain concentration.
Sample preparation of chondroitin sulfate
Tablet samples were weighed to ±265 mg, then placed with 10 mL 
of NaOH 6N in a 100 ml glass beaker. This was heated at 60°C for 
30 minutes with stirring, cooled, neutralized to pH 7 with HCl 2N, 
then diluted with 10 ml of methanol:water (2:1). The solution was 
centrifuged at 3500 rpm for 10 minutes, and 5 mL dichloromethane 
was added. The solution was shaken for 5 minutes, then allowed to 
separate. The water layer was filtered with a 0.45 μm filter membrane, 
then Aqua Bidest was added and diluted to a certain concentration.
Preparation of cream sample solution
Sample preparation of glucosamine HCl
The cream was weighed out in equivalents of ±250 mg, then dissolved 
in 10 ml of methanol:water (2:1) and the solution was centrifuged at 
3500 rpm for 10 minutes. Next, 5 ml of dichloromethane was added and 
the solution was shaken for 5 minutes, then allowed to separate. The 
water layer was filtered with a 0.45 μm filter membrane, and then Aqua 
Bidest was added and diluted to a certain concentration.
Sample preparation of chondroitin sulfate
The cream was weighed in equivalents of ±5 g and then added to 
10 ml of NaOH 6N in a 100 ml glass beaker. This was heated at 60°C 
for 30 minutes with stirring, then cooled and neutralized to pH 7 with 
2N HCl. The solution was then diluted with 10 ml of methanol:water 
(2:1) and centrifuged at 3500 rpm for 10 minutes. Next, 5 ml of 
dichloromethane was added and the solution was shaken for 5 minutes, 
and then allowed to separate. The water layer was filtered with a 
0.45 μm filter membrane, and then Aqua Bidest was added and diluted 
to a certain concentration.
Derivatization
Pipettes of 100 μl of standard solutions of glucosamine HCl and 
chondroitin sulfate were placed in a vial at a concentration of 
100 μg/ml, 50 μl of OPA/2-ME reagent was added, and the mixture was 
homogenized with a vortex for 20 seconds. This was allowed to react for 
2 minutes and was then analyzed with the HPLC system (Figs. 1 and 2).
RESULTS AND DISCUSSION
Analyses of glucosamine HCl and chondroitin sulfate levels were 
performed with pre-column derivatization using OPA with the addition 
of 2-mercaptoethanol (2-ME). Both of these form fluorescent compounds 
that can be detected. OPA/2-ME is commonly used as a reagent to improve 
the detection of amino acids. It reacts with the primary amine group 
substrate to form isoindole derivatives with high molar absorptivity 
of UV light (chromophores) or fluorescence groups (fluorophores). 
Glucosamine has primary amine groups (NH2) that can be derivatized 
with OPA/2-ME, while chondroitin has an acetyl group on the amine. 
Thus, NaOH is used to break the bond between the acetyl group (COCH3) 
and the nitrogen atom to form primary amine groups (NH2) [9,10].
Optimization of derivatization reagent volume and incubation 
time
Experiments were conducted to determine the volume of OPA/2-ME 
reagents required to produce optimum and stable derivatives (Table 1). 
Volumes of 25 μl, 50 μl, and 100 μl were analyzed, and the 50 μl volume 
showed larger peak areas and was more stable in both compounds. 
Derivatization produces perfect derivative compounds, so the analyte 
must be incubated after derivatization at a specific time (Table 2). 
Table 1: Optimization of derivatization reagent volume
Volume (μl) Area (µv/s)











Table 2: Incubation times
Time (minutes) Area
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Derivatization was compared at 2, 5, and 10 minutes, and the results 
showed that the optimum derivatization time was 2 minutes.
Chromatography optimization
The following parameters were optimized, among others: Column type, 
mobile phase composition, flow rate, injection volume, and injection 
method. The selected column was the YMC-Triart® C18 (250 × 4.6 mm, 
5 μm). The injection method was manual, and the injection volume was 
20 μl. Optimization of the mobile phase was performed by isocratic 
elution by changing the ratio of the mobile phase (THF 0.25% in water-
acetonitrile) with the composition ratio (70:30, 80:20, 85:15, 87:13, 
89:11, and 95:5), at a flow rate of 1.5 ml/minute. Two injections were 
performed. The results for optimization of mobile phase and flow rate 
are shown in Tables 3 and 4.
Validation
Linearity and range
The calibration curve consisted of a minimum six standard solutions in 
a linear range of 5-80 μg/mL for glucosamine HCl and 100-1000 μg/ml 
for chondroitin sulfate. Linearity was used to observe whether the 
results were directly or mathematically proportional to the analyte 
concentration of a sample in a given range. Linearity met the acceptance 
criteria if the correlation (r) was ≥0.99 [11]. The results are shown in 
Table 5.
Limits of detection (LOD) and limits quantitation (LOQ)
The LOD and LOQ are important for determining the lower concentration 
limit of a substance that can still be determined accurately and 
precisely. The LOD and LOQ for glucosamine HCl and chondroitin 
sulfate were calculated statistically through the line of linear regression 
from the calibration curve. LOD and LOQ values for glucosamine HCl 
and chondroitin sulfate are shown in Table 6.
Selectivity
The results of 20 μl injections of a placebo solution (matrix tablets and 
creams) were analyzed under the selected optimum conditions. There 
was no interference in compound’s retention times, which proves that 
the analytical methods were selective for the glucosamine HCl and 
Fig. 1: Derivatization reaction of glucosamine hydrochloride [11,12]
Fig. 2: Derivatization reaction of chondroitin sulfate [10]
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chondroitin sulfate derivatives. The chromatograms of selectivity can 
be seen in Figs. 3 and 4, and the chromatogram of the standard solution 
is shown in Fig. 5.
Accuracy and precision
Accuracy is a measure of the closeness of the test result or the average 
value of the set of data against the true value. In this study, we used the 
spiked placebo recovery method with a range of concentrations at 80%, 
100%, and 120% (three replicas per concentration). The accuracy met 
the acceptance criteria if the recovery value was 98-100%. Precision 
or repetition tests were measured by calculating the coefficient of 
variation (%CV) data of three replicas for each concentration. The 
acceptance criteria of CV were 2% (≤2%) [12]. The results are shown 
in Tables 7-10.
Assay
The validated method was used to analyze two samples on the market 
containing glucosamine HCl and chondroitin sulfate. Levels were 
Table 4: Optimization of flow rate




HETP Number of theoretical 
plates (N)
R
G K G K G K G K
1/2 23.695 32.111 1.116 1.073 2.14×10−3 2.44×10−3 11696 10255 7.846
1/5 18.837 25.755 1.072 1.013 2.62×10−3 2.66×10−3 9540 9402 7.545
G: Glucosamine HCl, K: Chondroitin sulfate, R: Resolution, HCl: Hydrochloride
Table 7: Accuracy and precision of glucosamine HCl detection in 
tablet form
C (ppm) X (ppm) SD CV (%) Recovery (%)
25.6 25.33 98.93
25.84 0.26 1.01 100.94
25.65 100.18
32 31.98 99.93
32.08 0.06 0.20 100.26
32.09 100.28
38.4 37.81 98.48
37.94 0.10 0.27 98.81
37.74 98.27
C: Concentration, X: Measurable concentration, SD: Standard deviation; 
CV: Coefficient of variation, HCL: Hydrochloride
Fig. 3: Chromatogram of selectivity for tablet placebo
Fig. 4: Chromatogram of selectivity for cream placebo
Table 3: Optimization of mobile phase composition




Tf HETP Number of theoretical 
plates (N)
R
G K G K G K G K
(70:30) - - - - - - - - -
- - - - - - - - -
(80:20) 18.440 28.456 1.020 1.024 2.33×10−3 1.96×10−3 10740 12743 11.646
18.026 27.674 1.156 1.173 2.78×10−3 2.68×10−3 9001 9317 10.120
(85:15) 15.922 17.614 1.480 1.271 3.03×10−3 3.76×10−3 8238 6650 2.161
19.088 21.181 1.421 1.273 3.12×10−3 4.52×10−3 8007 5537 2.101
(87:13) 17.235 22.247 1.687 1.277 2.96×10−3 4.43×10−3 8441 5641 5.180
16.603 21.642 1.535 1.133 3.17×10−3 5.54×10−3 7884 4511 4.948
(89:11) 23.379 35.332 1.639 1.296 2.93×10−3 5.50×10−3 8531 4543 7.689
23.628 35.573 1.643 1.191 2.85×10−3 5.54×10−3 8782 4513 7.641
(95:5) 72.764 1.093 - 2.57×10−3 - 9730 - -
71.313 1.122 - 2.15×10−3 - 11648 - -
G: Glucosamine HCl, K: Chondroitin sulfate, R: Resolution, THF: Tetrahydrofuran, HETP: Height equivalent totheoretical plate, Tf: Tailing factor, HCl: Hydrochloride
Table 5: Linearity of glucosamine HCl and chondroitin sulfate
Solution a (intercept) b (slope) R
Glucosamine HCl −9714206 3418646 0.9989
Chondroitin sulfate −1457766 21894 0.9988
HCL: Hydrochloride
Table 6: LOD and LOQ values
Solution LOD (μg/ml) LOQ (μg/ml)
Glucosamine HCl 5.51 18.38
Chondroitin sulfate 154.81 516.02
LOD: Limits of detection, LOQ: Limits quantitation
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calculated using the onepoint measurement method. The average 
levels of glucosamine HCl and chondroitin sulfate in tablet form were 
Fig. 5: Chromatogram of standard solutions of glucosamine 
hydrochloride and chondroitin sulfate
Table 8: Accuracy and precision of chondroitin sulfate detection 
in tablet form
C (ppm) X (ppm) SD CV (%) Recovery (%)
640 646.90 101.08
652.25 7.34 1.14 101.91
637.75 99.65
800 806.41 100.80
800.15 6.01 0.75 100.02
812.17 101.52
960 841.08 98.03
970.69 17.95 1.87 101.10
973.52 101.41
C: Concentration, X: Measurable concentration, SD: Standard deviation, 
CV: Coefficient of variation
Table 9: Accuracy and precision of glucosamine HCl detection in 
cream form
C (ppm) X (ppm) SD CV (%) Recovery (%)
32 32.59 101.84
32.33 0.13 0.40 101.02
32.45 101.42
40 40.60 101.50
40.43 0.15 0.36 101.07
40.31 100.77
48 48.51 101.07
48.59 0.13 0.27 101.22
48.34 100.70
C: Concentration; X: Measurable concentration; SD: Standard deviation; 
CV: Coefficient of variation, HCL: Hydrochloride
Table 10: Accuracy and precision of chondroitin sulfate 
detection in cream form
C (ppm) X (ppm) SD CV (%) Recovery (%)
320 322.63 100.82
322.89 0.92 0.28 100.90
321.19 100.37
400 392.10 98.03
393.58 2.47 0.63 98.40
396.93 99.23
480 478.65 99.72
480.00 0.95 0.20 100.00
480.49 100.10
C: Concentration; X: Measurable concentration; SD: Standard deviation; 
CV: Coefficient of variation
Table 11: Determination of glucosamine HCl levels in tablet form




20 110857856 107179978 19.34 96.68
100539254 18.14 90.69
100793341 18.18 90.92
C: Concentration, HCL: Hydrochloride
Table 12: Determination of chondroitin sulfate levels in tablet form








92.76% and 96.11%, respectively. In cream form, the average levels of 
glucosamine HCl and chondroitin sulfate were 101.15% and 100.33%, 
respectively. The results are shown in Tables 11-14. Chromatogram 
samples are shown in Figs. 6 and 7.
Fig. 6: Chromatogram of tablet sample
Fig. 7: Chromatogram of cream sample
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CONCLUSION
The optimum conditions for determining glucosamine HCl and 
chondroitin sulfate in tablet and cream forms included the use of 
HPLC with a fluorescence detector at λex = 335 nm and λem = 445 nm, 
and a YMC-Triart® C18 column (length 250 mm, diameter 4.6 mm, 
and particle size 5 μm), a mobile phase of THF in water-acetonitrile 
(87:13), and a flow rate of 1.5 ml/minute. The optimum conditions 
for the hydrolysis of chondroitin sulfate involved NaOH and heating 
for 30 minutes at 60°C. A mixture of glucosamine HCl, and chondroitin 
sulfate was derivatized with 50 μl of OPA/2-ME reagent, and then 
incubated for 2 minutes, and 20.0 μl was injected into the HPLC system. 
The validation method for glucosamine HCl and chondroitin sulfate met 
the acceptance criteria of accuracy, precision, selectivity, and linearity.
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